HOME Top Market Reports RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: September 2014
Report Code: BT 2766

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global transcriptomics market was valued at $1,743.2 in 2013. This market is expected to reach $3,773.0 million by 2019 at a CAGR of 13.7% from 2014 to 2019. In this report, the global transcriptomics market is segmented as by technology, by applications, and by end-users. Market by technology comprises of microarray, PCR, sequencing, and RNAi gene silencing technologies whereas, the market by applications include clinical diagnostics, drug discovery, and toxicogenomics. The market by end-users includes pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers.

The transcriptomics market has witnessed significant growth in the past few years mainly due to the increasing technological advancements in the field of ‘omics’ research and application of sequencing technologies in RNA Analysis research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. Similarly, the application of RNA Analysis in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of RNA Analysis products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent.

The RNA Analysis technologies market comprises of microarray, PCR, sequencing including Sanger sequencing and NGS, and RNAi gene silencing. Each of these technologies are further segmented into reagents, instruments, and software. PCR technology has dominated the market due to its increasing application in RNA sequencing.. However, the sequencing segment including NGS is expected to grow at a higher CAGR due the increase in read lengths facilitated by this technology, reduced costs, and faster sequencing from existing platforms.

North America holds the largest share of the global transcriptomics market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, and India) and Latin America are expected to form new revenue-generating pockets for the market players. Economic developments and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.

The market is dominated by players such as Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.) and Thermofisher Scientific Inc. (U.S.).

Scope of the Report

RNA Analysis is the study of the complete set of RNAs (transcriptome) encoded by the genome of a specific cell or organism at a specific time or under a specific set of conditions. RNA Analysis has significant applications in the field of pharmaceuticals and biotechnology and is used in the drug discovery, life science research, and clinical diagnostic applications. Transcriptomics has its application

Global Transcriptomics Market

This research report categorizes the global RNA Analysis market into the following segments:

By technology

  • Microarray
    • Reagents
    • Instruments
    • Software
  • PCR
    • Reagents
    • Instruments
    • Software
  • Sequencing
    • Sanger Sequencing
      • Reagents
      • Instruments
      • Software
    • NGS
      • Reagents
      • Instruments
      • Software
  • RNAi Gene Silencing
    • Reagents
    • Instruments
    • Software

By applications

  • Clinical Diagnostics
  • Drug Discovery
  • Toxicogenomics

By End-users

  • Pharmaceutical and biotechnology Companies
  • Academic Research and Government Institutes
  • Hospitals and Diagnostic Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
  • Asia-Pacific
    • China
    • India
    • Japan
    • RoAP
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa

Table of Contents 
 
1 Introduction (Page No.- 16)
    1.1 Objectives of the Study
    1.2 Markets Covered
    1.3 Stakeholders
    1.4 Market Scope

2 Research Methodology (Page No.- 20)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Crackdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Key Data From Secondary Sources
    2.6 Key Data From Primary Sources
          2.6.1 Key Industry Insights
    2.7 Assumptions for the Study

3 Executive Summary (Page No.- 30)

4 Premium Insights (Page No.- 31)

5 Market Overview (Page No.- 32)
    5.1 Introduction
    5.2 Evolution
    5.3 Market Segmentation
          5.3.1 Transcriptomics Market, By Type
          5.3.2 Transcriptomics Market, By Application
          5.3.3 Global Transcriptomics Market, By End User
    5.4 Market Dynamics
    5.5 Key Market Drivers
          5.5.1 Growing Applications of Rna Sequencing in Transcriptomic Research to Drive Market Growth
          5.5.2 Increased Research and Development Spending By Biotechnology Companies to Boost RNA Analysis Market
          5.5.3 Increasing Preference for Personalized Medicine to Further Propel RNA AnalysisTechnologies Market
          5.5.4 Availability of Government and Private Funding to Drive Transcriptomic Technologies Market
    5.6 Key Market Restraints
          5.6.1 Need of High Capital Investment Limits Adoption of Transcriptomic Technologies
          5.6.2 Dearth of Skilled Professionals Hindering Greater Adoption of Transcriptomic Technologies
    5.7 Key Market Opportunities
          5.7.1 Significant Opportunities for Transcriptomic Technologies in the Field of Biomarker Discovery
          5.7.2 Emerging and Untapped Markets  Present Opportunities
          5.7.3 Toxicogenomics As An Application to Open New Growth Avenues
    5.8 Key Challenges
          5.8.1 Lack of Effective Bioinformatics tools for Transcriptomic Analysis

6 Industry Trends (Page No.- 45)
    6.1 Introduction
    6.2 Industry Trends
    6.3 Porter’s Five forces Analysis
    6.4 Value Chain
    6.5 Strategic Benchmarking

7 Transcriptomics Technologies Market, By Type (Page No.- 46)
    7.1 Introduction
    7.2 Microarrays
          7.2.1 Reagents
          7.2.2 Instruments
          7.2.3 Software
    7.3 Polymerase Chain Reaction (PCR)
          7.3.1 Reagents
          7.3.2 Instruments
          7.3.3 Software
    7.4 Sequencing Technologies
          7.4.1 Sanger Sequencing
                   7.4.1.1 Reagents
                   7.4.1.2 Instruments
                   7.4.1.3 Software
          7.4.2 Next Generation Sequencing (NGS)
                   7.4.2.1 Reagents
                   7.4.2.2 Instruments
                   7.4.2.3 Software
    7.5 RNAI Gene Silencing
          7.5.1 Reagents
          7.5.2 Instruments
          7.5.3 Software

8 Global Transcriptomics Market, By Application (Page No.- 63)
    8.1 Introduction
          8.1.1 Clinical Diagnosis
          8.1.2 Drug Discovery
          8.1.3 Toxicogenomics

9 Global Transcriptomics Market, By End User (Page No.- 67)
    9.1 Introduction
          9.1.1 Academic Research & Government Institutes
          9.1.2 Pharmaceutical & Biotechnology Companies
          9.1.3 Hospitals & Diagnostic Centers

10 Global Transcriptomics Market, By Geography (Page No.- 70)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
             10.2.3 Mexico
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (ROE)
     10.4 Asia-Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World
             10.5.1 Latin America
             10.5.2 Middle East & Africa

11 Company Profiles (Page No.- 113)
     11.1 Affymetrix Inc.
             11.1.1 Business Overview
             11.1.2 Products & Services
             11.1.3 Key Strategy
             11.1.4 Recent Developments
             11.1.5 SWOT Analysis
             11.1.6 MNM View
     11.2 Agilent Technologies, Inc.
             11.2.1 Business Overview
             11.2.2 Products & Services
             11.2.3 Key Strategy
             11.2.4 Recent Developments
             11.2.5 SWOT Analysis
             11.2.6 MNM View
     11.3 Bio-Rad Laboratories, Inc.
             11.3.1 Business Overview
             11.3.2 Products & Services
             11.3.3 Key Strategy
             11.3.4 Recent Developments
     11.4 GE Healthcare
             11.4.1 Business Overview
             11.4.2 Products & Services
             11.4.3 Key Strategy
             11.4.4 Recent Developments
     11.5 Illumina, Inc.
             11.5.1 Business Overview
             11.5.2 Products & Services
             11.5.3 Key Strategy
             11.5.4 Recent Developments
             11.5.5 SWOT Analysis
             11.5.6 MNM View
     11.6 Qiagen N.V.
             11.6.1 Business Overview
             11.6.2 Products & Services
             11.6.3 Key Strategy
             11.6.4 Recent Developments
             11.6.5 SWOT Analysis
             11.6.6 MNM View
     11.7 F. Hoffmann-La Roche Ltd.
             11.7.1 Business Overview
             11.7.2 Products & Services
             11.7.3 Key Strategy
             11.7.4 Recent Developments
     11.8 Sigma-Aldrich Corporation
             11.8.1 Business Overview
             11.8.2 Products & Services
             11.8.3 Key Strategy
             11.8.4 Recent Developments
     11.9 Thermo Fisher Scientific, Inc.
             11.9.1 Business Overview
             11.9.2 Products & Services
             11.9.3 Key Strategy
             11.9.4 Recent Developments
             11.9.5 SWOT Analysis
             11.9.6 MNM View
     11.10 Fluidigm Corporation
             11.10.1 Business Overview
             11.10.2 Products & Services
             11.10.3 Key Strategy
             11.10.4 Recent Developments

12 Competitive Landscape (Page No.- 146)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends

13 Appendix (Page No.- 147)
     13.1 Insights of Industry Experts
     13.2 Available Customizations
     13.3 Related Reports
     13.4 Introducing RT: Real Time Market Intelligence
 
 
List of Tables (217 Tables) 
  
Table 1 Growing R&D Spending and Increasing Preference for Personalized Medicines to Fuel Growth of RNA Analysis Market
Table 2 Need of High Capital Investment and Dearth of Skilled Professionals May Limit Uptake of Transcriptomic Technologies
Table 3 Novel Biomarker Discovery and Toxicogenomics to Open New Growth Opportunities
Table 4 Lack of Effective Bioinformatics Tools Poses the Biggest Challenge for Transcriptomic
Table 5 Global Transcriptomics Market Size, By Technology, 2012–2019 ($Million)
Table 6 Global RNA Analysis Market Size, By Geography 2012-2019 ($Million)
Table 7 Global Transcriptomics Microarray Market Size, By Product, 2012–2019 ($Million)
Table 8 Global RNA Analysis Microarray Market Size, By Geography, 2012–2019 ($Million)
Table 9 Global Transcriptomic Microarray Reagents Market Size, By Geography, 2012–2019 ($Million)
Table 10 Global Transcriptomic Microarray Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 11 Global RNA Analysis Microarray Software Market Size, By Geography, 2012–2019 ($Million)
Table 12 Global Transcriptomics PCR Market Size, By Product, 2012–2019 ($Million)
Table 13 Global Transcriptomics PCR Market Size, By Geography, 2012–2019 ($Million)
Table 14 Global RNA Analysis PCR Reagents Market Size, By Geography, 2012–2019 ($Million)
Table 15 Global Transcriptomics PCR Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 16 Global Transcriptomics PCR Software Market Size, By Geography, 2012–2019 ($Million)
Table 17 Global RNA Analysis Sequencing Market Size, By Product, 2012-2019 ($Million)
Table 18 Global Transcriptomics Sequencing Market Size, By Geography, 2012–2019 ($Million)
Table 19 Global Transcriptomics Sanger Sequencing Market Size, By Product, 2012–2019 ($Million)
Table 20 Global RNA Analysis Sanger Sequencing Market Size, By Geography, 2012–2019 ($Million)
Table 21 Global Transcriptomic Sanger Sequencing Reagents Market Size, By Geography, 2012–2019 ($Million)
Table 22 Global RNA Analysis Sanger Sequencing Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 23 Global Transcriptomics Sanger Sequencing Software Market Size, By Geography, 2012–2019 ($Million)
Table 24 Global Transcriptomics NGS Market Size, By Product, 2012–2019 ($Million)
Table 25 Global RNA Analysis NGS Market Size, By Geography, 2012–2019 ($Million)
Table 26 Global Transcriptomics NGS Reagents Market Size, By Geography, 2012–2019 ($Million)
Table 27 Global Transcriptomics NGS Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 28 Global RNA Analysis NGS Software Market Size, By Geography, 2012–2019 ($Million)
Table 29 Global Transcriptomics RNAI Gene Silencing Market Size, By Product, 2012–2019 ($Million)
Table 30 Global Transcriptomics RNAI Gene Silencing Market Size, By Geography, 2012–2019 ($Million)
Table 31 Global Transcriptomics RNAI Gene Silencing Reagents Market Size, By Geography, 2012–2019 ($Million)
Table 32 Global Transcriptomics RNAI Gene Silencing Instruments Market Size, By Geography, 2012–2019 ($Million)
Table 33 Global Transcriptomics RNAI Gene Silencing Software Market Size, By Geography, 2012–2019 ($Million)
Table 34 Global RNA Analysis Market Size, By Application, 2012–2019 ($Million)
Table 35 Global Transcriptomics Market Size for Clinical Diagnostics, By Geography, 2012–2019 ($Million)
Table 36 Global Transcriptomics Market Size for Drug Discovery, By Geography, 2012–2019 ($Million)
Table 37 Global Transcriptomics Market Size for Clinical Toxicogenomics, By Geography, 2012–2019 ($Million)
Table 38 Global RNA Analysis Market Size, By End User, 2012–2019 ($Million)
Table 39 Global Transcriptomics Market Size for Academic Research & Government Institutes, By Geography, 2012–2019 ($Million)
Table 40 Global Transcriptomics Market Size for Pharmaceutical & Biotechnology Companies, By Geography, 2012–2019 ($Million)
Table 41 Global Transcriptomics Market Size for Hospitals & Diagnostic Centers, By Geography, 2012–2019 ($Million)
Table 42 Global Transcriptomics Market Size, By Geography, 2012–2019 ($Million)
Table 43 North America: Transcriptomics Market Size, By Country, 2012–2019 ($Million)
Table 44 North America: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 45 North America: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 46 North America: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 47 North America: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 48 North America: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 49 North America: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 50 North America: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 51 North America: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 52 North America: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 53 U.S. : Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 54 U.S. : RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 55 U.S.: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 56 U.S.: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 57 U.S.: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 58 U.S.: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 59 U.S.: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 60 U.S.: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 61 U.S.: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 62 Canada : Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 63 Canada: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 64 Canada : Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 65 Canada: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 66 Canada : RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 67 Canada: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 68 Canada: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 69 Canada: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 70 Canada: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 71 Mexico: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 72 Mexico: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 73 Mexico: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 74 Mexico: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 75 Mexico: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 76 Mexico: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 77 Mexico: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 78 Mexico: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 79 Mexico: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 80 Europe: Transcriptomics Market Size, By Country, 2012–2019 ($Million)
Table 81 Europe: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 82 Europe: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 83 Europe: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 84 Europe: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 85 Europe: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 86 Europe: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 87 Europe: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 88 Europe: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 89 Europe: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 90 Germany: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 91 Germany: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 92 Germany: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 93 Germany : Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 94 Germany: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 95 Germany: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 96 Germany: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 97 Germany: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 98 Germany: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 99 U.K.: Transcriptomics Market Size, By Product, 2012–2019 ($Million)
Table 100 U.K.: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 101 U.K.: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 102 U.K.: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 103 U.K.: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 104 U.K.: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 105 U.K.: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 106 U.K.: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 107 U.K.: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 108 France: Transcriptomics Technologies Market Size, By Product, 2012–2019 ($Million)
Table 109 France: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 110 France: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 111 France: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 112 France: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 113 France: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 114 France: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 115 France: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 116 France: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 117 Italy: Transcriptomics Technologies Market Size, By Product, 2012–2019 ($Million)
Table 118 Italy: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 119 Italy: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 120 Italy: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 121 Italy: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 122 Italy: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 123 Italy: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 124 Italy: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 125 Italy: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 126 Spain: Transcriptomics Technologies Market Size, By Product, 2012–2019 ($Million)
Table 127 Spain : RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 128 Spain: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 129 Spain: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 130 Spain: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 131 Spain: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 132 Spain: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 133 Spain: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 134 Spain: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 135 ROE: Transcriptomics Technologies Market Size, By Product, 2012–2019 ($Million)
Table 136 ROE: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 137 ROE: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 138 ROE: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 139 ROE: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 140 ROE: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 141 ROE: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 142 ROE: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 143 ROE: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 144 Asia-Pacific: Transcriptomics Market Size, By Country, 2012–2019 ($Million)
Table 145 Asia-Pacific: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 146 Asia-Pacific: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 147 Asia-Pacific: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 148 Asia-Pacific: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 149 Asi-Pacific: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 150 Asia-Pacific: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 151 Asia-Pacific: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 152 Asia-Pacific: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 153 Asia-Pacific: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 154 China: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 155 China: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 156 China: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 157 China: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 158 China: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 159 China: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 160 China: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 161 China: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 162 China: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 163 Japan: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 164 Japan: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 165 Japan: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 166 Japan: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 167 Japan: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 168 Japan: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 169 Japan: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 170 Japan: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 171 Japan: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 172 India: Transcriptomics Market Size, By Type, 2012–2019 ($Million)
Table 173 India: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 174 India: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 175 India: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 176 India: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 177 India: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 178 India: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 179 India: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 180 India: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 181 ROAPAC: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 182 ROAPAC: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 183 ROAPAC: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 184 ROAPAC: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 185 ROAPAC: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 186 ROAPAC: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 187 ROAPAC: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 188 ROAPAC: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 189 ROAPAC: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 190 ROW: Transcriptomics Market Size, By Region, 2012–2019 ($Million)
Table 191 ROW: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 192 ROW: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 193 ROW: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 194 ROW: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 195 ROW: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 196 ROW: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 197 ROW: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 198 ROW: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 199 ROW: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 200 Latin America: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 201 Latin America: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 202 Latin America: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 203 Latin America: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 204 Latin America: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 205 Latin America: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 206 Latin America: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 207 Latin America: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 208 Latin America: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
Table 209 Middle East & Africa: Transcriptomics Technologies Market Size, By Type, 2012–2019 ($Million)
Table 210 Middle East & Africa: RNA Analysis Microarray Technologies Market Size, By Product, 2012–2019 ($Million)
Table 211 Middle East & Africa: Transcriptomics PCR Technologies Market Size, By Product, 2012–2019 ($Million)
Table 212 Middle East & Africa: Transcriptomics Sequencing Technologies Market Size, By Type, 2012–2019 ($Million)
Table 213 Middle East & Africa: RNA Analysis Sanger Sequencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 214 Middle East & Africa: Transcriptomics NGS Technologies Market Size, By Product, 2012–2019 ($Million)
Table 215 Middle East & Africa: Transcriptomics RNAI Gene Silencing Technologies Market Size, By Product, 2012–2019 ($Million)
Table 216 Middle East & Africa: Transcriptomics Market Size, By Application, 2012–2019 ($Million)
Table 217 Middle East & Africa: Transcriptomics Market Size, By End User, 2012–2019 ($Million)
 
 
List of Figures (20 Figures) 
 
Figure 1 Research Methodology
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Technological Advancements to Play Vital Role in the Omics Industry
Figure 7 Market Segmentation: By Type
Figure 8 Global Market: By Application
Figure 9 Global Market, By End User
Figure 10 Key Market Dynamics
Figure 11 Affymetrix Inc. : Company Snapshot
Figure 12 Agilent Technologies Inc. : Company Snapshot
Figure 13 Bio-Rad Laboratories Inc.: Company Snapshot
Figure 14 General Electric Co. : Company Snapshot
Figure 15 Illumina Inc. : Company Snapshot
Figure 16 Qiagen N.V.: Company Snapshot
Figure 17 F. Hoffmann-La Roche Ltd : Company Snapshot
Figure 18 Sigma Aldrich: Company Snapshot
Figure 19 Thermofisher Scientific Inc. : Company Snapshot
Figure 20 Fluidigm Corporation: Company Snapshot

The global transcriptomics market was valued at $1,743.2 million in 2013 and is expected to reach at $3,773.0 million by 2019, at a CAGR of 13.7% during the forecast period of 2014 to 2019. This market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent

The global market covers transcriptomic technologies, applications, and end-users. The RNA Analysis technologies market is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented as reagents, instruments and software. The applications of RNA analysis covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of RNA analysis are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets. The global market is divided into four major geographies, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW).

North America holds the largest share of the global transcriptomics market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, and India) and Latin America are expected to form new revenue-generating pockets for the market players. Economic developments and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.

The prominent players in the market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

Global Transcriptomics Technologies Market, by Type (2014-2019)

RNA Analysis/Trancriptomics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports